✦ LIBER ✦

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

✍ Scribed by Bassan, R.; Spinelli, O.; Oldani, E.; Intermesoli, T.; Tosi, M.; Peruta, B.; Rossi, G.; Borlenghi, E.; Pogliani, E. M.; Terruzzi, E.; Fabris, P.; Cassibba, V.; Lambertenghi-Deliliers, G.; Cortelezzi, A.; Bosi, A.; Gianfaldoni, G.; Ciceri, F.; Bernardi, M.; Gallamini, A.; Mattei, D.; Di Bona, E.; Romani, C.; Scattolin, A. M.; Barbui, T.; Rambaldi, A.

Book ID: 125538644
Publisher: American Society of Hematology
Year: 2009
Tongue: English
Weight: 449 KB
Volume: 113
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2008-11-185132

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Status of minimal residual disease after

Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study

✍ Jerzy Holowiecki; Malgorzata Krawczyk-Kulis; Sebastian Giebel; Krystyna Jagoda; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Use of Allogeneic Hematopoietic Stem-Cel

Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group

✍ Eckert, C.; Henze, G.; Seeger, K.; Hagedorn, N.; Mann, G.; Panzer-Grumayer, R.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 227 KB

Population-based study of the pattern of

Population-based study of the pattern of molecular markers of minimal residual disease in childhood and adult acute lymphoblastic leukemia: An assessment of the practical difficulty of representative sampling for trial purposes

✍ Middleton, P.G.; Norden, J.; Levett, D.; Levasseur, M.; Miller, S.; Irving, J.A. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background. The prevalence, in unselected patients with acute lymphoblastic leukaemia (ALL), of clonal rearrangements suitable for minimal residual disease (MRD) studies has not been formally investigated. Procedure. This was a prospective, demographic study of the frequency of molecular markers of

Molecular detection of minimal residual

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group

✍ Biondi, A; Valsecchi, M G; Seriu, T; D’Aniello, E; Willemse, M J; Fasching, K; P 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 91 KB

Minimal residual disease-directed risk s

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

✍ Flohr, T; Schrauder, A; Cazzaniga, G; Panzer-Grümayer, R; van der Velden, V; Fis 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 353 KB

Treatment of High-Risk Philadelphia Chro

Treatment of High-Risk Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

✍ Ribera, J.-M.; Oriol, A.; Morgades, M.; Montesinos, P.; Sarra, J.; Gonzalez-Camp 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 261 KB